A rapid screening assay for inhibitors of 11β-hydroxysteroid dehydrogenases (11β-HSD): Flavanone selectively inhibits 11β-HSD1 reductase activity

Molecular and Cellular Endocrinology

Volumn 212, Issue 1-2, 2003, Pages 41-49

  Schweizer, Roberto A S ^a   Atanasov, Atanas G ^a   Frey, Brigitte M ^a   Odermatt, Alex ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

11 Hydroxysteroid dehydrogenase; Endocrine disruptor; Environmental chemical; Flavonoid; Glucocorticoid; Inhibitor

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; 2' HYDROXYFLAVANONE; CARBAMIC ACID DERIVATIVE; CORTISONE; FLAVANONE; FLAVONE; GLUCOCORTICOID; HYDROCORTISONE; MINERALOCORTICOID RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; BIOAVAILABILITY; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HYDROXYLATION; HYPERTENSION; IC 50; IN VIVO STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATION; PRIORITY JOURNAL; REDUCTION; SCREENING TEST; SODIUM RETENTION;

EID: 0344844573     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2003.09.027     Document Type: Article

References (34)

1. Adlercreutz H., Markkanen H., Watanabe S. Plasma concentrations of phyto-oestrogens in Japanese men. Lancet. 342:1993;1209-1210.
2. Alberts P., Engblom L., Edling N., Forsgren M., Klingstrom G., Larsson C., Ronquist-Nii Y., Ohman B., Abrahmsen L. Selective inhibition of 11beta-hydroxysteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycaemic mice. Diabetologia. 45:2002;1528-1532.
3. Anderson J.W., Johnstone B.M., Cook-Newell M.E. Meta-analysis of the effects of soy protein intake on serum lipids. N. Engl. J. Med. 333:1995;276-282.
4. Barf T., Vallgarda J., Emond R., Haggstrom C., Kurz G., Nygren A., Larwood V., Mosialou E., Axelsson K., Olsson R., Engblom L., Edling N., Ronquist-Nii Y., Ohman B., Alberts P., Abrahmsen L. Arylsulfonamidothiazoles as a new class of potential antidiabetic drugs. Discovery of potent and selective inhibitors of the 11beta-hydroxysteroid dehydrogenase type 1. J. Med. Chem. 45:2002;3813-3815.
5. Barnes P.J. Anti-inflammatory actions of glucocorticoids: molecular mechanisms. Clin. Sci. (Lond.). 94:1998;557-572.
6. Bertram C., Trowern A.R., Copin N., Jackson A.A., Whorwood C.B. The maternal diet during pregnancy programs altered expression of the glucocorticoid receptor and type 2 11beta-hydroxysteroid dehydrogenase: potential molecular mechanisms underlying the programming of hypertension in utero. Endocrinology. 142:2001;2841-2853.
7. Bisson M., Hontela A. Cytotoxic and endocrine-disrupting potential of atrazine, diazinon, endosulfan, and mancozeb in adrenocortical steroidogenic cells of rainbow trout exposed in vitro. Toxicol. Appl. Pharmacol. 180:2002;110-1107.
8. DiSilvestro R.A., Rogers D.L., Lee H.G. Diethyldithiocarbamate inhibition of galactosamine-induced hepatitis in rats. Pharmacol. Res. 45:2002;253-255.
9. Escher G., Galli I., Vishwanath B.S., Frey B.M., Frey F.J. Tumor necrosis factor alpha and interleukin 1beta enhance the cortisone/cortisol shuttle. J. Exp. Med. 186:1997;189-198.
10. Fernandez M.A., Tornos M.P., Garcia M.D., de las Heras B., Villar A.M., Saenz M.T. Anti-inflammatory activity of abietic acid, a diterpene isolated from Pimenta racemosa var. grissea. J. Pharm. Pharmacol. 53:2001;867-872.
11. Ferrari P., Sansonnens A., Dick B., Frey F.J. In vivo 11beta-HSD-2 activity: variability, salt-sensitivity, and effect of licorice. Hypertension. 38:2001;1330-1336.
12. Godfrey K.M., Barker D.J. Fetal nutrition and adult disease. Am. J. Clin. Nutr. 71:2000;1344S-1352S.
13. Gomez-Sanchez E.P., Gomez-Sanchez C.E. Central hypertensinogenic effects of glycyrrhizic acid and carbenoxolone. Am. J. Physiol. 263:1992;E1125-E1130.
14. Hoyer P.B. Reproductive toxicology: current and future directions. Biochem. Pharmacol. 62:2001;1557-1564.
15. Hult M., Jornvall H., Oppermann U.C. Selective inhibition of human type 1 11beta-hydroxysteroid dehydrogenase by synthetic steroids and xenobiotics. FEBS Lett. 441:1998;25-28.
16. Jha H.C., von Recklinghausen G., Zilliken F. Inhibition of in vitro microsomal lipid peroxidation by isoflavonoids. Biochem. Pharmacol. 34:1985;1367-1369.
17. Krazeisen A., Breitling R., Moller G., Adamski J. Phytoestrogens inhibit human 17beta-hydroxysteroid dehydrogenase type 5. Mol. Cell Endocrinol. 171:2001;151-162.
18. Lathers C.M. Endocrine disruptors: a new scientific role for clinical pharmacologists? Impact on human health, wildlife, and the environment. J. Clin. Pharmacol. 42:2002;7-23.
19. Le Bail J.C., Pouget C., Fagnere C., Basly J.P., Chulia A.J., Habrioux G. Chalcones are potent inhibitors of aromatase and 17beta-hydroxysteroid dehydrogenase activities. Life Sci. 68:2001;751-761.
20. Lesage J., Blondeau B., Grino M., Breant B., Dupouy J.P. Maternal undernutrition during late gestation induces fetal overexposure to glucocorticoids and intrauterine growth retardation, and disturbs the hypothalamo-pituitary adrenal axis in the newborn rat. Endocrinology. 142:2001;1692-1702.
21. Lindsay R.S., Lindsay R.M., Edwards C.R., Seckl J.R. Inhibition of 11-beta-hydroxysteroid dehydrogenase in pregnant rats and the programming of blood pressure in the offspring. Hypertension. 27:1996;1200-1204.
22. Masuzaki H., Paterson J., Shinyama H., Morton N.M., Mullins J.J., Seckl J.R., Flier J.S. A transgenic model of visceral obesity and the metabolic syndrome. Science. 294:2001;2166-2170.
23. Messina M.J., Persky V., Setchell K.D., Barnes S. Soy intake and cancer risk: a review of the in vitro and in vivo data. Nutr. Cancer. 21:1994;113-131.
24. Morton M.S., Wilcox G., Wahlqvist M.L., Griffiths K. Determination of lignans and isoflavonoids in human female plasma following dietary supplementation. J. Endocrinol. 142:1994;251-259.
25. New M.I., Wilson R.C. Steroid disorders in children: congenital adrenal hyperplasia and apparent mineralocorticoid excess. Proc. Natl. Acad. Sci. U.S.A. 96:1999;12790-12797.
26. Odermatt A., Arnold P., Stauffer A., Frey B.M., Frey F.J. The N-terminal anchor sequences of 11beta-hydroxysteroid dehydrogenases determine their orientation in the endoplasmic reticulum membrane. J. Biol. Chem. 274:1999;28762-28770.
27. Ohno S., Shinoda S., Toyoshima S., Nakazawa H., Makino T., Nakajin S. Effects of flavonoid phytochemicals on cortisol production and on activities of steroidogenic enzymes in human adrenocortical H295R cells. J. Steroid Biochem. Mol. Biol. 80:2002;355-363.
28. Reidenberg M.M. Environmental inhibition of 11beta-hydroxysteroid dehydrogenase. Toxicology. 144:2000;107-111.
29. San Feliciano A., Gordaliza M., Salinero M.A., Miguel del Corral J.M. Abietane acids: sources, biological activities, and therapeutic uses. Planta. Med. 59:1993;485-490.
30. Setchell K.D., Zimmer-Nechemias L., Cai J., Heubi J.E. Exposure of infants to phyto-oestrogens from soy-based infant formula. Lancet. 350:1997;23-27.
31. Stewart P.M., Krozowski Z.S. 11Beta-hydroxysteroid dehydrogenase. Vitam. Horm. 57:1999;249-324.
32. Sun K., Yang K., Challis J.R. Glucocorticoid actions and metabolism in pregnancy: implications for placental function and fetal cardiovascular activity. Placenta. 19:1998;353-360.
33. Sun K., He P., Yang K. Intracrine induction of 11beta-hydroxysteroid dehydrogenase type 1 expression by glucocorticoid potentiates prostaglandin production in the human chorionic trophoblast. Biol. Reprod. 67:2002;1450-1455.
34. White P.C., Mune T., Agarwal A.K. 11Beta-hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess. Endocr. Rev. 18:1997;135-156.